drug resistance

You have access
Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan
SUGURU OGATA, TOMOYA SUDOU, FUMIHIKO FUJITA, TAKEFUMI YOSHIDA, KENICHI KOUSHI, TAKASHI NOGUCHI, JUNYA FUKUDA, NANAE OGATA, YOSHITAKA NOBUKUNI and YOSHITO AKAGI

Anticancer Research August 2022, 42 (8) 4011-4016; DOI: https://doi.org/10.21873/anticanres.15897
You have access
Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression
LENA HUBER, RICHARD BIRK, MANUEL KNUETTEL, NICOLE ROTTER, CHRISTOPH ADERHOLD, CLAUDIA SCHERL, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER

Anticancer Research July 2022, 42 (7) 3403-3411; DOI: https://doi.org/10.21873/anticanres.15827
You have access
Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC
PARISA PRATHAPHAN, ONRAPAK REAMTONG, UTAPIN NGAOKRAJANG, TAVAN JANVILISRI, NAPACHANOK MONGKOLDHUMRONGKUL SWAINSON and PICHAMON KIATWUTHINON

Anticancer Research July 2022, 42 (7) 3507-3522; DOI: https://doi.org/10.21873/anticanres.15837
You have access
Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance
YUNMOON OH, JIN-SOL LEE, JI SUN LEE, JAE HYEON PARK, HYUNG SIK KIM and SUNGPIL YOON

Anticancer Research May 2022, 42 (5) 2433-2442; DOI: https://doi.org/10.21873/anticanres.15722
You have access
Circulating Tumor Cells Derived from Advanced Hepatocellular Carcinoma Rapidly Develop Resistance to Cytotoxic Chemotherapy
CHIA-HSUN HSIEH, CHAU-TING YEH, YA-HUI HUANG and MING-WEI LAI

Anticancer Research May 2022, 42 (5) 2479-2486; DOI: https://doi.org/10.21873/anticanres.15726
You have access
Ko143 Reverses MDR in Glioblastoma via Deactivating P-Glycoprotein, Sensitizing a Resistant Phenotype to TMZ Treatment
SAMUEL D. LUSTIG, SRAVAN K. KODALI, SHARON L. LONGO, SOMANATH KUNDU and MARIANO S. VIAPIANO

Anticancer Research February 2022, 42 (2) 723-730; DOI: https://doi.org/10.21873/anticanres.15530
You have access
Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen
GABRIELLA BIANCA HENRIQUES PALMA and MANDEEP KAUR

Anticancer Research January 2022, 42 (1) 565-579; DOI: https://doi.org/10.21873/anticanres.15514
Open Access
Lurasidone Sensitizes Cancer Cells to Osimertinib by Inducing Autophagy and Reduction of Survivin
SHUHEI SUZUKI, MASAHIRO YAMAMOTO, TOMOMI SANOMACHI, KEITA TOGASHI, SHIZUKA SEINO, ASUKA SUGAI, TAKASHI YOSHIOKA, MASASHI OKADA and CHIFUMI KITANAKA

Anticancer Research September 2021, 41 (9) 4321-4331; DOI: https://doi.org/10.21873/anticanres.15237
You have access
Estrogen Receptor β Is Involved in Acquired Resistance to EGFR-tyrosine Kinase Inhibitors in Lung Cancer
HIROKI SUGIURA, YASUHIRO MIKI, ERINA IWABUCHI, RYOKO SAITO, KATSUHIKO ONO, IKURO SATO, YOSHINORI OKADA and HIRONOBU SASANO

Anticancer Research May 2021, 41 (5) 2371-2381; DOI: https://doi.org/10.21873/anticanres.15012
You have access
Biological Activity of a Thiobarbituric Acid Compound in Neuroblastomas
SANG Y. LEE, BECKY SLAGLE-WEBB, ARUN K. SHARMA and JAMES R. CONNOR

Anticancer Research March 2021, 41 (3) 1171-1181; DOI: https://doi.org/10.21873/anticanres.14874

Main menu

User menu

Search

drug resistance

Pages